Back

(-75)G allele of APOA1 gene is associated with non-attainment of target lipid levels in very high cardiovascular risk patients

29 April 2017 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Molecular biology - Genetics Molecular biology / genetics HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Svetlana Villevalde

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

4 More presentations in this session

Presentation thumbnail
Doctor D. Snipelisky (Rochester, US)
Abstract Slides
Presentation thumbnail
Doctor L. Liberata Barbosa Bandeira (Norwich, GB)
Presentation thumbnail
Doctor N. Jankovic (Belgrade, RS)
Abstract
Presentation thumbnail
Professor O. Blagova (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Molecular biology - Genetics

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The differences in lipid lowering therapies and the LDL-C goal attainment in patients with ASCVD documented by cardiologists and general practitioners in Germany.
30 August 2025
thumbnail
Congress Presentation
Genotyping of patients with severe dyslipidemia in a screening program for familial hypercholesterolemia. Studio Gioconda.
13 April 2023
thumbnail
Congress Presentation
Association of body mass index with non-achievement of target low-density lipoprotein level in older patients at very high cardiovascular risk: a multicentre study
27 August 2021
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
7 October 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources